Summary & Overview
HCPCS A4250: Urine Test or Reagent Strips or Tablets (100)
HCPCS Level II code A4250 denotes a supply of urine test or reagent strips or tablets in a package of 100. This code is used to bill for diagnostic testing supplies that enable point-of-care or home urine analysis for conditions such as glucose monitoring, ketones, protein, or other routine urine parameters. Nationally, accurate coding for these supplies matters because it affects coverage determinations, patient access to home-monitoring tools, and how payers reimburse durable medical equipment and supply lines.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the code’s clinical context and typical settings of use, plus guidance on the types of benchmarks and policy topics commonly associated with supply codes: coverage criteria across major payers, billing and documentation considerations, and how this supply category interacts with outpatient and home health services. The publication also outlines common modifiers and administrative elements (Data not available in the input for payor-specific rates and taxonomies) and points readers to areas where payer policy updates or prior authorization rules often appear. This summary provides a concise national perspective for providers, billing professionals, and policy analysts seeking to understand the role of A4250 in outpatient and home diagnostic testing workflows.
Billing Code Overview
HCPCS Level II code A4250 describes urine test or reagent strips or tablets (100 tablets or strips). The service is the provision of urine testing materials used to detect analytes or measure parameters in urine samples for clinical monitoring or diagnostic screening. The typical service type is diagnostic test supplies, and the usual site of service is outpatient settings or home use where patients or caregivers perform point-of-care or home-based urine testing.
Clinical & Coding Specifications
Clinical Context
A typical outpatient or home-care patient with diabetes mellitus or suspected urinary tract conditions receives A4250 reagent strips (100 strips) for urine testing. The patient is seen in a primary care clinic, endocrinology clinic, home health visit, or skilled nursing facility. The clinician assesses symptoms (polyuria, polydipsia, dysuria, fever, or changes in mental status in elderly patients) and orders point-of-care urine dipstick testing to screen for glucose, ketones, blood, protein, leukocyte esterase, nitrites, pH, and specific gravity.
In a clinic visit the medical assistant or nurse performs the dipstick and documents results in the chart; abnormal results prompt follow-up actions such as repeat testing, urine culture, serum testing, medication changes, or referral. For patients managing diabetes at home, A4250 may be dispensed to the patient or home health nurse for serial self-testing to monitor glycosuria or ketonuria during illness. Typical workflow steps: order/dispense A4250, perform or instruct dipstick testing, document results, and code supplies and any associated evaluation or procedures separately when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |